Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ASP Isotopes (ASPI) EBIT (2023 - 2025)

Historic EBIT for ASP Isotopes (ASPI) over the last 3 years, with Q3 2025 value amounting to -$15.0 million.

  • ASP Isotopes' EBIT fell 17545.04% to -$15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$42.5 million, marking a year-over-year decrease of 8714.24%. This contributed to the annual value of -$26.4 million for FY2024, which is 6427.91% down from last year.
  • According to the latest figures from Q3 2025, ASP Isotopes' EBIT is -$15.0 million, which was down 17545.04% from -$12.0 million recorded in Q2 2025.
  • ASP Isotopes' 5-year EBIT high stood at -$3.7 million for Q1 2023, and its period low was -$15.0 million during Q3 2025.
  • Moreover, its 3-year median value for EBIT was -$5.8 million (2024), whereas its average is -$7.0 million.
  • Within the past 5 years, the most significant YoY rise in ASP Isotopes' EBIT was 3676.0% (2025), while the steepest drop was 17545.04% (2025).
  • Quarter analysis of 3 years shows ASP Isotopes' EBIT stood at -$4.0 million in 2023, then tumbled by 90.1% to -$7.6 million in 2024, then plummeted by 95.7% to -$15.0 million in 2025.
  • Its EBIT was -$15.0 million in Q3 2025, compared to -$12.0 million in Q2 2025 and -$8.0 million in Q1 2025.